Monte dei Paschi's cash call 93% covered so far despite low shareholder take-up


Cash call 74% covered by shareholders, state accounts for 64%


Sub-underwriters to put in 475 mln euros


Overall take-up seen rising above current 93%

By Valentina Za

MILAN, Oct 31 (Reuters) - Italy's Monte dei Paschi di Siena BMPS.MI said its up to 2.5 billion euro ($2.5 billion) capital increase had been 93% covered so far thanks to accords with investors that offset in part a low take-up by the bank's shareholders.

Monday was the last day for shareholders in the world's oldest bank to exercise rights to buy into its seventh cash call in 14 years.

When excluding the state, which contributed 1.6 billion euros towards the capital raising based on its 64% stake, shareholders only took it up for another 10%, Monte dei Paschi (MPS) said.

MPS said it had raised a total of 1.847 billion euros from existing shareholders.

However, it added it had placed another 475 million euros' worth of new shares with investors who had signed binding sub-underwriting accords.

These investors include MPS' insurance partner AXA AXAF.PA , holders of the bank's junior bonds such as funds Pimco, Melqart and BlueBay, plus several Italian banking foundations, which are under Treasury oversight and have been urged to help out.

Taking into account these commitments, MPS said it could count on a total of 2.3 billion euros, a figure which could further rise in the following two days.

Unexercised rights will be sold on the Milan bourse on Tuesday and Wednesday, and that is expected to further reduce the amount underwriters will be saddled with below 100 million euros.

The group of eight banks plus London-based fund Algebris that have agreed to back the capital raising will pocket much higher than normal fees to offset likely losses on the new shares.

The have also demanded that MPS struck sub-underwriting accords covering at least half of the 900 million euro portion of the share sale that had to be financed by private investors due to European Union rules on state aid.

Given its shrunken market value in relation to the size of the cash call, MPS has been forced to price the new shares above the multiples at which healthier peers trade, leading analysts to expect a drop in price as soon as they start trading.

($1 = 1.0117 euros)
Reporting by Valentina Za Editing by Keith Weir and David Evans

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.